about
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cellsTargeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cellsSurvivin safeguards chromosome numbers and protects from aneuploidy independently from p53Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell.Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma.Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas.A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs)Carboxylated N-glycans on RAGE promote S100A12 binding and signaling.tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cellsD-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancerRNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivoDifferential growth inhibition of cerebral metastases by anti-angiogenic compoundsEngineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation.Chimeric antigen receptor-engineered T cells for immunotherapy of cancer.Tumor evasion from T cell surveillance.Highly specific overexpression of the transcription factor SOX11 in human malignant gliomas.Janus face-like effects of Aurora B inhibition: antitumoral mode of action versus induction of aneuploid progeny.Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy.Overcoming concealment effects of targeting moieties in the PEG corona: controlled permeable polymersomes decorated with folate-antennae for selective targeting of tumor cells.Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.Retargeting of human regulatory T cells by single-chain bispecific antibodies.SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells.Silencing of selected glutamate receptor subunits modulates cancer growth.Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats.Giant cell glioblastoma is associated with altered aurora b expression and concomitant p53 mutation.Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11.The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate.Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity.D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family.Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy.Storage stability of optimal liposome-polyethylenimine complexes (lipopolyplexes) for DNA or siRNA delivery.Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax.D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.Glutamate receptors in pediatric tumors of the central nervous system.Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice.Increased p21(ras) activity in human fibroblasts transduced with survivin enhances cell proliferation.MPTH-11ANAPLASTIC MENINGIOMAS WHO GRADE III LACK OF SOMATIC AKT1-MUTATIONS AND SHOW AN OVEREXPRESSION OF EGF-RECEPTORS.
P50
Q27345360-0AC79FF1-60DA-4640-A897-5E9D035A0352Q28301522-6711E0FF-E215-480F-8FD3-99D4B369E871Q30579633-ADFA4870-A2F3-4C22-B090-A9A91F864E0BQ30881604-9DC1DFA0-E1D7-401D-9945-8C82433AD496Q33200791-7F902BA8-8A9E-4B0C-85D9-D3F6FD5D0039Q33777905-DEB75CB9-359E-4843-8CB7-3771ED3AEFFBQ33809058-025466A1-17F8-4033-B8E8-78203C7F5C57Q33890233-6A2E0B12-2F1C-4D60-88D1-6B3FF58CEE22Q34214788-E842730B-8A57-488A-A2DD-9418F122F526Q34341383-28E5BC3D-02A2-4A94-89E5-7583D31E2849Q34584439-2B7CF723-EC46-4688-8D2F-D6720843CA3FQ35225270-201eb03a-4935-8423-3699-4fe4cf1364e2Q35304863-4167C2AB-24F0-49EA-BB71-FAA52B9D0ED9Q35597405-448BE1D7-AA25-456A-B8C5-8E58E692602BQ36544158-A383911A-2C0C-47C1-91C0-9DA3EE6550F9Q37751873-5593F8BA-8257-49BC-BC18-7CED98073C9AQ37970674-2E8DCB4B-CFCC-4CD9-9028-D736879A93EAQ38333407-F36AC784-FE61-4849-AE8C-C1A7CA2BFDADQ38752357-9DB7BDE0-A05D-49A4-BC30-0FDC02DAA9E2Q38850379-F310E21B-0124-4A85-9156-6BF075FE193CQ38903397-084B000A-68E3-4479-9B08-15C67E22CE22Q38943361-41295552-4944-e4c5-49ce-9b5852daa055Q38972549-C759CB0A-E9B5-4223-AB62-855E65347186Q39425238-F5741846-7540-4CB8-82C5-E4F122A75F7CQ39445843-83b5aaa4-46c5-fd3d-ad13-d842a3236ae6Q39464328-50FB5E27-5181-46F1-805E-EE1EF5DA1D86Q39548378-33090419-9B5A-4A42-BA19-4B3FF9EEFAD8Q39704126-6F03E088-7275-4BC7-9317-2CBC277B392FQ40310994-2A533CF4-6880-4F81-B8ED-73DEC5CA25C7Q40329983-6BA261F5-B0D4-4A1D-B523-CFE982434718Q40445064-99349F4D-2127-4146-9D10-8BB294531CFBQ40447853-E72B692D-320A-4FBD-9124-84C7D9117129Q40851513-01AC2395-7D4B-4B1B-BF24-1A0A5087B622Q42233978-9E216508-1B11-4A23-B7CD-877EFAF4700EQ42503763-4B20850C-E187-4A1F-8C4F-54B7F3E259ADQ42622527-0F9DEE28-E813-4BFD-B5ED-17A5489642E3Q43198339-1A805EC8-4868-44D4-BBAD-95627D438EB5Q43997205-085C9C64-65CD-452C-9B1C-8D113EA99D88Q45223067-14FAC060-C6AF-4EB9-A642-103C61D87AF2Q45834003-A125936C-D84A-406F-A3A0-5C6ABB6B70F9
P50
description
german researcher
@en
wetenschapper
@nl
name
Achim Temme
@ast
Achim Temme
@en
Achim Temme
@es
Achim Temme
@nl
type
label
Achim Temme
@ast
Achim Temme
@en
Achim Temme
@es
Achim Temme
@nl
altLabel
Hanns Achim Temme
@en
prefLabel
Achim Temme
@ast
Achim Temme
@en
Achim Temme
@es
Achim Temme
@nl
P106
P21
P31
P4872
P496
0000-0001-5084-1180